source
- Medtronic and Given Imaging issue early alert for Bravo CF esophageal pH capsule delivery devices due to attachment failuresThe FDA's Center for Devices and Radiological Health issued an Early Alert about a potential high‑risk issue with Medtronic’s Bravo CF esophageal pH monitoring capsule delivery devices. The proble…
- Akeso CEO says biliary tract cancer data could be a breakthroughAkeso’s chief executive Michelle Xia told ChinaPharma that the company’s PD-1xVEGF bispecific antibody, ivonescimab, is generating strong interest after early biliary tract cancer results. She not…